Antidote Appoints Dr. Laurent Schockmel As New CEO

NEW YORK, NY & LONDON, UK--(October 11, 2018) Antidote Technologies, the digital health company that connects patients with medical research, today announced that Dr. Laurent Schockmel has been appointed as Chief Executive Officer. He will assume day-to-day leadership of the Company and will also join Antidote’s Board of Directors. Founder and former CEO, Pablo Graiver, will continue to support the company as President.

"I started Antidote to help patients access new treatments which could lead to new cures for all of us and for future generations," said Graiver, "and I’m very proud of the difference our mission-driven team has made in patients’ lives to date. We’re now starting an exciting new stage in Antidote’s growth, and Laurent, with his rich background in life sciences, proven operational experience, and shared passion for our vision, is exactly what we needed to propel the business forward."

Dr. Schockmel is a 30-year veteran of the life sciences, technology, data and services industries. With deep experience in clinical and commercial settings in the U.S. and Europe, he has served in leadership roles at organizations such as Truveris, IMS Health, Cegedim and Gemini Consulting. Dr. Schockmel has a track record of achieving dramatic advancements in customer innovation, quality, efficiency and overall company performance.

"I am thrilled to assume this role at Antidote," said Schockmel. "I look forward to working closely with Antidote’s Board and talented team to continue innovating and delivering significant value to our customers, partners, employees and shareholders."